Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial by Vent, Alexandra et al.








Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate
(sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A
double-blind, randomized, placebo-controlled, crossover trial
Vent, Alexandra ; Surber, Christian ; Graf Johansen, Nicole Tracy ; Figueiredo, Verena ; Schönbächler,
Georg ; Imhof, Laurence ; Buset, Caroline ; Hafner, Jürg
Abstract: Background: Neutralizing (buffering) lidocaine 1%/epinephrine 1:100,000 solution (Lido/Epi)
with sodium hydrogen carbonate (NaHCO3) (also called sodium bicarbonate) is widely used to reduce
burning sensations during infiltration of Lido/Epi. Optimal mixing ratios have not been systematically
investigated. Objectives: To determine whether a Lido/Epi:NaHCO3 mixing ratio of 3:1 (investigational
medicinal product 1) causes less pain during infiltration than a mixing ratio of 9:1 (IMP2) or unbuffered
Lido/Epi (IMP3). Methods: Double-blind, randomized, placebo-controlled, crossover trial (n = 2 × 24)
with 4 investigational medicinal products (IMP1-4). Results: The 3:1 mixing ratio was significantly less
painful than the 9:1 ratio (P = .044). Unbuffered Lido/Epi was more painful than the buffered Lido/Epi
(P = .001 vs IMP1; P = .033 vs IMP2). IMP4 (NaCl 0.9% [placebo]) was more painful than any of
the anesthetic solutions (P = .001 vs IMP1; P = .001 vs IMP2; P = .016 vs IMP3). In all cases, the
anesthesia was effective for at least 3 hours. Limitations: Results of this trial cannot be generalized to
other local anesthetics such as prilocaine, bupivacaine, or ropivacaine, which precipitate with NaHCO3
admixtures. Conclusions: Lido/Epi-NaHCO3 mixtures effectively reduce burning pain during infiltration.
The 3:1 mixing ratio is significantly less painful than the 9:1 ratio. Reported findings are of high practical
relevance, given the extensive use of local anesthesia today.
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Background: Neutralizing (buffering) lidocaine 1%/epinephrine 1:100,000 solution (Lido/Epi) with sodium 
hydrogen carbonate (NaHCO3) (also called sodium bicarbonate) is widely used to reduce burning 
sensations during infiltration of Lido/Epi. Optimal mixing ratios have not been systematically investigated. 
 
Objectives: To determine whether a Lido/Epi:NaHCO3 mixing ratio of 3:1 (investigational medicinal product 
[1]) causes less pain during infiltration than a mixing ratio of 9:1 (IMP2) or unbuffered Lido/Epi (IMP3). 
 
Methods: Double-blind, randomized, placebo-controlled, crossover trial (n = 2 3 24) with 4 
investigational medicinal products (IMP1-4). 
 
Results: The 3:1 mixing ratio was significantly less painful than the 9:1 ratio (P = .044). Unbuffered 
Lido/Epi was more painful than the buffered Lido/Epi (P = .001 vs IMP1; P = .033 vs IMP2). IMP4 
(NaCl 0.9% [placebo]) was more painful than any of the anesthetic solutions (P = .001 vs IMP1; P = 
.001 vs IMP2; P = .016 vs IMP3). In all cases, the anesthesia was effective for at least 3 hours. 
 
Limitations: Results of this trial cannot be generalized to other local anesthetics such as prilocaine, 
bupivacaine, or ropivacaine, which precipitate with NaHCO3 admixtures. 
 
Conclusions: Lido/Epi-NaHCO3 mixtures effectively reduce burning pain during infiltration. The 3:1 mixing ratio is 
significantly less painful than the 9:1 ratio. Reported findings are of high practical relevance, given the extensive 
use of local anesthesia today. ( J Am Acad Dermatol https://doi.org/10.1016/j.jaad.2019.09.088.) 
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Lidocaine, an anesthetic of the amide class, is one  of  
the  most  commonly  used  local anesthetics. It is 
available in a variety of concentrations (0.5%-2.5%). A 
concentration of 1%,  
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with or without epinephrine, is the most commonly 
used. Epinephrine is added at a concentration of 
1:100,000; it causes vasoconstriction, resulting in less 
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To aid manufacture and stability, commercial auxiliary  substances  such  as  sulfites,  pregnancy 
lidocaine products  with  or without  epinephrine (confirmed  with  testing),  damaged  skin  on  the 
have a pH of 2.5 to 4.0.
2-4
 Acidity is assumed to be arms, or inability to give informed consent.  
responsible  for  the  burning  sensation  during       
infiltration.
5
 Seventeen peer-reviewed studies have Investigational medicinal products  
confirmed   significant   pain   reduction   during Four investigational medicinal products (IMP1-4) 
infiltration  of  lidocaine  when  sodium  hydrogen were prepared and labeled according to a packaging 
carbonate  (NaHCO3,  also     and randomization plan by 
called sodium bicarbonate) 
CAPSULE SUMMARY 
  the hospital pharmacy of the 
8.4% was added in various 
   
University Hospital  Zurich,      
mixing ratios (10:1 to 5:1) to     according to current good 
buffer  the  solution  at  a 
d 
Admixture of sodium hydrogen  manufacturing practice.  To 
neutral, more physiologic  carbonate significantly reduces the  ensure  a blind  test and 
pH.
1,6
 All studies consistently  strong burning sensation during  to guarantee product confor- 
reported that buffering did  infiltration of lidocaine 1% with  mity/stability on the day of 
not reduce or shorten the  epinephrine (1:100,000). The  injection, IMPs 1 through 4 
anesthetic effect.  recommended ratios vary from 5:1 to  were prepared as sets of 2 
Based on this information,  10:1.   identical  vials  (5  mL):  1 
it has become common to 
d 
This double-blind, randomized, placebo-  containing  NaHCO3  and  1 
mix lidocaine 1%/epineph-  controlled, crossover trial shows the  containing Lido/Epi in 
rine 1:100,000  (Lido/Epi) 
  
appropriate  concentrations.  superiority of a 3:1 mixing ratio over a  
with NaHCO3 at a 9:1 ratio 
  
For further details, see Fig 2.  9:1 ratio or unbuffered lidocaine.  
(9 mL Lido/Epi plus 1 mL      The mixing took place within 
NaHCO3 8.4%). In daily prac-     1 minute before infiltration. 
tice, however, many patients still report distressing This procedure was explicitly chosen to guarantee 
pain during infiltration. Therefore, we empirically product conformity/stability.    
extended mixing ratios and found that a 3:1 ratio led       
to virtually painless infiltrations.   Injection sites and injection procedure  
To scientifically substantiate our observation, we Group 1 received 2 infiltrations. The injection sites 
conducted a phase 2, monocentric, double-blind, ran- were on the palmar aspect of the right and left 
domized, placebo-controlled crossover trial to assess forearms.     
pain during infiltration of 2 solutions with different Group 2 received 4 infiltrations into the palmar 
ratios of Lido/Epi:NaHCO3 (3:1 and 9:1), unbuffered aspect of the forearms. The injection sites were the 
Lido/Epi, and sodium chloride (NaCl) 0.9% (placebo). radial portion of the palmar aspect of the right 
       forearm, the ulnar portion of the palmar aspect of 
MATERIALS AND METHODS  the right forearm, the ulnar portion of the palmar 
Approvals     aspect of the left forearm, and the radial portion of 
The study was approved by the local ethical com- the palmar aspect of the left forearm.   
mittee (KEK-ZH, Nr.2015-0531) and by Swissmedic, the All sites were 5 cm distal from the cubital fossa. 
national supervisory authority for drugs and medical Five seconds after skin puncture, 2 mL of the IMP was 
products in Switzerland. Written informed consent was slowly infiltrated into the superficial subcutis over a 
obtained from all volunteers. The trial was registered at period of 15 s with a 30-gauge needle. The residual 
www.clinicaltrial.gov (NCT03110393). 8 mL in the syringe was discarded. The injections 
       were  performed  by  the  same  study  physician 
Volunteers     throughout  the  investigation.  The  mixed  study 
A total of 48 healthy volunteers were included and medication was at room temperature.   
distributed  to  2  groups.  In  each  group,  every       
volunteer  was  randomly  allocated  to  receive pH and osmolality of IMPs    
injections in a different order (Fig 1). The pH of the IMPs was determined with a Titrando 
Inclusion  criteria  were  age  18  to  75  years, 906 potentiometer (Metrohm, Herisau, Switzerland), 
proficiency in German, and sufficient intellectual according  to  European  Pharmacopoeia  2.2.3. 
and linguistic abilities to fully understand and follow Osmolality  of  the IMPs  was determined with 
all trial procedures and instructions. the  Advanced-3320  micro-osmometer  (Advanced 
Exclusion  criteria  were  hypersensitivity  or Instruments, Norwood MA) according to European 










IMP: investigational medicinal product 
Lido/Epi: lidocaine 1%/epinephrine 1:100,000 
NaCl: sodium chloride 
NaHCO3: sodium hydrogen carbonate (also 
called sodium bicarbonate) 
NRS: numeric rating scale 
 
 
Measuring parameters and hypotheses  
The following 3 measurements were recorded: 
pain during infiltration, patient comfort during 
infiltration, and duration of local anesthesia 
(numbness).  
Quantitative rating of pain during infiltration 
was recorded on a 10-point numeric rating scale 
(NRS) immediately after infiltration of the study 
solution (a few seconds after removing the 
needle). For each volunteer, data were recorded 
on a sheet of paper with a NRS (from 0, no pain 
to 10, unacceptable pain).
7 
 
Qualitative rating of patient comfort during 
infiltration was recorded by using a sheet of paper 
with a choice of 4 categorical terms: desirable  
(wunschenswert€), acceptable (akzeptabel ), less 
acceptable (weniger akzeptabel ), and almost or 
totally unacceptable (kaum oder gar nicht 
akzeptabel ), which could be ticked off by the 
volunteers. This was done directly after recording 
the pain during infiltration (NSR) measurement.  
The duration of local anesthesia (numbness) was 
recorded after infiltration (after recording the pain 
during infiltration and patient comfort during 
infiltration) within 3 to 5 minutes of removing of the 
needle and at 30-minute intervals up to 3 hours, 
each time using a standardized laser stimulus that 
left the skin barrier intact (erbium:glass nonablative 
fractional laser: 1540 nm; 10-mm tip; fluence, 30 mJ; 
pulse width, 15 ms; Cynosure Inc, Langen, 
Germany).
8
 Numbness was recorded as present 
(yes) or absent (no).  
The following hypotheses were tested for pain 
during infiltration:  
Group 1 (primary endpoint): 
d IMP 1 (Lido/Epi:NaHCO3 ratio, 3:1) causes less 
pain during infiltration than IMP 2 (Lido/ 
Epi:NaHCO3 ratio, 9:1). 
 
Group 2 (secondary endpoints): 
d IMP 1 (Lido/Epi:NaHCO3 ratio, 3:1) causes less 
pain during infiltration than IMP 3 (unbuffered 
Lido/Epi) and IMP4 (placebo).  
d IMP 2 (Lido/Epi:NaHCO3 ratio, 9:1) causes less 
pain during infiltration than IMP 3 (unbuffered 


























Fig 1. Consolidated Standards of Reporting Trials 
(CONSORT) study flow diagram. IMP 1: 
Lido/Epi:NaHCO3 ratio, 3:1; IMP 2: Lido/Epi:NaHCO3 
ratio, 9:1; IMP 3: Lido/Epi without NaHCO3. IMP 4: 
NaCl 0.9% (placebo). IMP, Investigational medicinal 
product; Lido/Epi, lidocaine 1%/epinephrine 1:100,000; 
NaCl, sodium chloride; NaHCO3, sodium bicarbonate; 
RCT, randomized controlled trial. 
 
Statistics  
Group 1, primary endpoint (n 5 24). We planned for 
a 2-sided Mann-Whitney test of the Collaboration in 
Research and Methodology for Official Statistics 
estimator, measured as the score for pain on 
infiltration of the first injection minus the score for 
pain on infiltration of the second injection. We 
estimated that 24 crossovers would be needed to 
have at least 80% power with significance testing at 
the a = .05 level to detect a difference between the 
2 randomization groups (2 different orders of the 
injection sequence) of 3 NRS values, assuming a 
standard deviation of 2.5. Variability was estimated 
based on a 2010 Cochrane review.
6 
 
Group 2, secondary endpoints (n 5 24). We 
decided to test all 4 IMPs on a second group of 
volunteers to avoid possible interference with the 
investigation of the primary endpoint (IMP 1 vs 
IMP 2). Every volunteer of group 2 was randomly 
allocated a different order of injections.  
The randomization list was computer generated by 
the hospital pharmacy, with block sizes of 6 for group 1 
(4 blocks of 6 participants; 3 started with IMPs 1 and 3 
with IMP 2) and 1 block of 24 participants for group 2 
(this block contained 24 possible combinations).  
The tests for differences in pain during 
infiltration are based on a 2-sided exact Mann-


































Fig 2. Investigational medicinal products 1 through 4 were prepared, labeled, and packed 
according to a randomization list (double-blinded to study participants and physicians). 
IMP, Investigational medicinal product; Lido/Epi, lidocaine 1%/epinephrine 1:100,000; 




Patient comfort during infiltration and local 
anesthesia (numbness) information were analyzed 
descriptively. All analyses were performed in the R 




A total of 48 volunteers were included (21 men, 
27 women), with mean age of 31.4 years (range, 
21-62 years). All of them completed the study. 
 
Pain measurements  
Quantitative rating of pain during infiltration. Group 1. 
IMP 1 (Lido/Epi:NaHCO3  ratio, 3:1) was  
significantly  less  painful  than  IMP  2 
(Lido/Epi:NaHCO3  ratio, 9:1) (P 5 .044). When IMP  
1  was  followed  by  IMP  2,  IMP  1  had  a median 
pain score 1.5 points lower (less painful) than IMP 2 
(interquartile range, 3.0 to 21.0). When IMP 2 was 
followed by IMP 1, the IMP 1 median pain score was 
0.5 points lower than for IMP 2 (inter-  
quartile range, 22.0 to 1.25) (Fig 3).  
Group 2. IMP 3 (unbuffered Lido/Epi) was more 
painful than both IMP 1 (Lido/Epi:NaHCO3 ratio, 
3:1) (P = .001) and IMP 2 (Lido/Epi:NaHCO3 
ratio, 9:1) (P = .033). IMP 4 (placebo) was more 
painful than IMP 1 (P = .001), IMP 2 (P = .001), 




For IMP 1, the median NRS score was 2.0 
(interquartile range, 1.0-4.0). For IMP 2, the median 
NRS score was 3.0 (interquartile range, 2.0-4.25). For 
IMP 3, the median NRS score was 4.5 (interquartile 
range, 3.0-7.0). Finally, for IMP 4, the median NRS 
score was 6.0 (interquartile range, 3.75-8.0). 
Qualitative rating of patient comfort during  
infiltration. Qualitative rating score data are  
presented in Fig 5. [F5-4/C]  
Duration of local anesthesia (numbness). In  
all volunteers, laser-induced pain was absent in 
the injection areas of IMPs 1, 2, and 3 and was 
present in the injection areas of IMP 4 between 5 
minutes and 3 hours after infiltration.  
pH and osmolality of IMPs. The pH informa-tion 
is presented in Fig 2. The osmolality values for 
IMPs 1, 2, 3, and 4 were 674.6, 467.1, 315.0, 
285.3 mosm/kg, respectively. 
 
Adverse events  
No serious adverse events occurred during the 
study. Five test persons experienced local 
tenderness for 1 to 2 days. One test person had a 
deep subcutaneous nodule of approximately 5-
mm diameter, which completely disappeared after 
2 months. We assume it must have been a small 

























Fig 3. Quantitative rating of pain during infiltration, IMP 
1 versus IMP 2. Group 1 (n = 24), primary endpoint. 
The volunteers of group 1 compared IMP 1 versus IMP 
2 in a randomized sequence (block randomization, 4 
blocks of 6 volunteers). IMP 1 was significantly less 
painful during infiltration than IMP 2 (P = .044). When 
IMP 1 was followed by IMP 2, IMP 1 had a median pain 
score 1.5 points lower (less painful) than IMP 2. When 
IMP 2 was followed by IMP 1, the IMP 1 median pain 
score was 0.5 points lower than for IMP 2.  
In the boxplots, the line in the box corresponds to the median; 
the lower and upper hinges correspond to the first and third 
quartiles, respectively; and the upper and lower whiskers 
extend from the hinge to the largest or smallest value, 
respectively, no further than 1.5 3 IQR from the hinge. The 
dots show each of the 24 NRS score points. IMP  
1: Lido/Epi:NaHCO3 ratio, 3:1; IMP 2: Lido/Epi:NaHCO3 
ratio, 9:1. IMP, Investigational medicinal product; IQR,  
interquartile range; Lido/Epi, lidocaine 1%/epinephrine 
1:100,000; NaHCO3, sodium bicarbonate; NRS, 
numeric rating scale. 
 
DISCUSSION  
In a phase 2, monocentric, double-blind, 
random-ized, placebo-controlled, crossover trial, 
we scientifically substantiated that the mixing of 
Lido/Epi:NaHCO3 at a 3:1 ratio causes less pain 
during infiltration than at a 9:1 ratio (Fig 3). 
Furthermore, we showed that unbuffered Lido/Epi 
is more painful than buffered Lido/Epi at ratios of 
3:1 and 9:1 and that the placebo was more painful 
than any of the anesthetic solutions (Fig 4). 
Patient comfort during infiltration, assessed with 
qualitative pain scores, showed a clear 
preference for the buffered Lido/Epi at a ratio of 
3:1. Placebo received the most negative scores 
(Fig 5). All anesthetic solutions led to numbness 
in the injection areas between 5 minutes and 3 
hours after infiltration. The lower lidocaine 
concentration in the 3:1 Lido/Epi:NaHCO3 did not 
affect local anesthesia, compared with the 9:1 





















Fig 4. Quantitative rating of pain during infiltration: IMP 1 
versus IMP3 and IMP4; IMP2 versus IMP3 and IMP 4. 
Group 2 (n = 24), secondary endpoint. The volunteers of 
group 2 compared IMP 1 versus IMP3 and IMP4 and 
compared IMP 2 versus IMP3 and IMP4 in a randomized 
sequence (block randomization, 1 block of 24 different 
combinations). Statistical significance was as follows: IMP 
1 versus IMP 3, P = .001; IMP 2 versus IMP 3, P = .033; 
IMP 1 versus IMP 4, P = .001; IMP 2 versus IMP 4, P = 
.001; IMP 3 versus IMP 4, P = .016.  
In the boxplots, the line in the box corresponds to the median; 
the lower and upper hinges correspond to the first and third 
quartiles, respectively; and the upper and lower whiskers 
extend from the hinge to the largest or smallest value, 
respectively, no further than 1.5 3 IQR from the hinge. The 
dots show each of the 24 NRS score points. IMP  
1: Lido/Epi:NaHCO3 ratio, 3:1; IMP 2: Lido/Epi:NaHCO3 
ratio, 9:1. IMP, Investigational medicinal product; IQR,  
interquartile range; Lido/Epi, lidocaine 1%/epinephrine 
1:100,000; NaHCO3, sodium bicarbonate; NRS, 
numeric rating scale. 
 
Acidity causes the burning sensation during 
infiltration  
Acidity has been assumed to be responsible for 
the burning sensation during infiltration, and the 
detection of acid-sensing ion channel receptors or 
nociceptors fully supports this explanation.
5
 The 
causal link between pH and burning pain during 
infiltration is also supported by our trial with the 
unbuffered Lido/Epi solution (IMP 3) at pH 3.8 and 
with the pharmacologically inactive placebo (IMP 4) 
at pH 6.3. The pain during infiltration with the 
neutralized solutions (IMP 1, pH 7.5; IMP 2, pH 7.3) 
was significantly reduced. 
 
At neutral pH, lidocaine is predominantly present 
in its active form  
Injection solutions contain lidocaine in an 
uncharged, nonionized form and in a charged, 
ionized form. The uncharged formdalso known as 






















Fig 5. Qualitative rating of patient comfort during 
infiltration of local anesthetics, captured with categorial 
terms. The first 2 bars represent results from group 1, 
and the next 4 bars represent results from group 2. IMP 
1: Lido/Epi:NaHCO3 ratio, 3:1; IMP 2: 
Lido/Epi:NaHCO3 ratio, 9:1. IMP, Investigational 
medicinal product; Lido/Epi, lidocaine 1%/epinephrine 
1:100,000; NaHCO3, sodium bicarbonate. 
 
charged (hydrophilic) form, readily permeates the 
nerve membrane to bind from the cytosol to the 
acid-sensing ion channel receptors.
10,11
 
According to the Henderson-Hasselbalch 
equation, in any sample of a lidocaine solution, 
the ratio of the nonionized (active form) to ionized 
species of the anesthetic depends on the pH. At a 
more acidic pH, the ionized cationic form 
predominates. For instance, at a pH of 3.8, a 
typical cartridge of Lido/Epi contains only 1 
molecule of nonionized (active form) anesthetic 
for every 10,000 molecules of ionized anesthetic. 
On the other hand, closer to physiologic pH, more 
nonionized (active form) anesthetic is present. For 
instance, at the physiologic pH 7.4, there is 1 
molecule of nonionized (active form) lidocaine in 
solution for every 4 molecules of ionized 
lidocaine. At the physiologic pH, 2500 times more 
of the active form is available than at a pH of 3.8. 
 
NaCl 0.9% is more painful than unbuffered 
Lido/Epi  
During injection of unbuffered Lido/Epi (pH 3.8), 
the buffering system of the body will bringdwith a 
very short time lagdthe nonphysiologic pH of the 
solution to a more neutral level.
12
 During 
neutralization, the continuously formed nonionized 
lidocaine (active form) can penetrate nerve cells and 
block the acid-sensing ion channel receptors from 
inside the synapse.
13,14
 With NaCl 0.9% (pH 6.3), 
the buffering system of the body will also neutralize 
the solution. However, due to the absence of 
lidocaine, acidity will cause a noticeably longer 





Carbon dioxide has analgesic effects 
When NaHCO3 is mixed with acidic lidocaine 
hydrochloride solution, water (H2O) and carbon 
dioxide (CO2) are formed. Condouris and 
Shakalis
15
 showed that CO2 develops an 
independent, direct local anesthetic effect. Based 
on these observations, Catchlove was able to 
demonstrate that CO2 enhances the action of 
lidocaine. CO2 directly deactivates the nerve 
axon and indirectly increases the anesthetic 
effect of lidocaine by changing its electrical 
charge.
16
 This may explain why an excess of 
CO2, as formed in a 3:1 mixture, more effectively 
reduces the burning sensation of lidocaine 
relative to the 9:1 mixture. Both mixtures 
effectively neutralize the Lido/Epi solution, but the 
3:1 mixture provides more local CO2 anesthesia. 
 
Osmolality and pain during infiltration Osmolality 
may impair tolerability (including pain  
on infiltration) of injection solutions.
17
 The general 
osmolality recommendation for injection and infusion 
solutions is to not greatly exceed 600 and 1000 
mOsm/kg, respectively.
17
 No mOsm/kg-to-pain 
relationship was found between 300 and 1100 
mOsm/kg in a study after intramuscular injection of 
vaccine suspensions in healthy adults.
18
 The 
osmolality of Lido/Epi:NaHCO3 at a ratio of 3:1 (IMP 
1) was 674.6 mosm/kg and higher than in the other 
solutions (467.1, 315.0, and 285.3 mosm/kg for 
IMPs 1, 2, and 3, respectively). In a similar 
investigation, Parham and Pasieka
19
 found that pain 
during infiltration of physiologic NaCl 0.9% (285.3 
mosm/kg) was significantly more painful than 
Lido/Epi-NaHCO3 mixtures that were more than 
twice as osmolar.
19
 Our data confirm this 
observation. 
 
Stability of bicarbonate-neutralized Lido/Epi 
solution  
The stability of neutralized Lido/Epi solutions with 
NaHCO3 is limited,
20
 which is the major reason why 
there are no commercial products on the market. 
Neutralized Lido/Epi solutions are compounded in 
advancedeither preoperatively by nurses or 
physicians or by a specialized pharmacy.
20
 The 
manner in which the solutions are mixed often 
depends on the available bulk containers 
(drug/buffer), syringes, and local situations and 
customs. This makes the storage and subsequent 
stability of the compounded product an important 
issue. Despite numerous examinations on the 
stability of neutralized anesthetics/epinephrine 
solutions, there is still a considerable degree of 






method validation and study design and the large 
number of influences when compounding (such as 
temperature, time, packaging material, light, and 
oxygen level), no general rules have emerged to 
simplify compounding and ensure product quality. In 
the context of our trial, we therefore limited the time 
between mixing and infiltrating the Lido/Epi-NaHCO3 
solution to 1 minute so that degradation would not 
be a factor. In our everyday practice, we limit the 
shelf life of the ad hoceprepared Lido/Epi-NaHCO3 





The Lido/Epi-NaHCO3 mixtures effectively 
reduce burning pain during infiltration. The 3:1 
mixing ratio was significantly less painful than the 
9:1 ratio. The reported findings are of high 
practical relevance, given the extensive use of 




The results of this clinical trial cannot be 
generalized to other local anesthetics, such as 
prilocaine, bupivacaine, or ropivacaine, which 
precipitate with bicarbonate admixture. NaHCO3 
admixtures with other concentrations of lidocaine 
(eg, 0.5% or 2.0%) and with lidocaine without 
epinephrine are expected to function the same 
way, but this has not been formally tested. 
 
This study was supported by the JH Rahn 
Foundation, Zurich (www.jhrahn-foundation.ch) and the 
Bruno Bloch Foundation, Zurich 
(www.brunoblochstiftung.ch). We thank all participants. 
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